nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—ALB—hematologic cancer	0.0544	1	CbGaD
Nortriptyline—ORM1—Imatinib—hematologic cancer	0.0249	0.0424	CbGbCtD
Nortriptyline—CYP1A2—Anagrelide—hematologic cancer	0.0201	0.0342	CbGbCtD
Nortriptyline—PTGS1—Bortezomib—hematologic cancer	0.0191	0.0326	CbGbCtD
Nortriptyline—PTGS1—Thalidomide—hematologic cancer	0.0167	0.0284	CbGbCtD
Nortriptyline—PTGS1—Ifosfamide—hematologic cancer	0.0147	0.025	CbGbCtD
Nortriptyline—PTGS1—Imatinib—hematologic cancer	0.014	0.0239	CbGbCtD
Nortriptyline—CYP2E1—Thalidomide—hematologic cancer	0.0129	0.0219	CbGbCtD
Nortriptyline—CYP2C9—Bexarotene—hematologic cancer	0.0126	0.0214	CbGbCtD
Nortriptyline—CYP2E1—Dacarbazine—hematologic cancer	0.0111	0.0188	CbGbCtD
Nortriptyline—CYP3A5—Daunorubicin—hematologic cancer	0.011	0.0187	CbGbCtD
Nortriptyline—CYP2D6—Lomustine—hematologic cancer	0.0107	0.0182	CbGbCtD
Nortriptyline—CYP1A2—Carmustine—hematologic cancer	0.0106	0.018	CbGbCtD
Nortriptyline—ALB—Imatinib—hematologic cancer	0.0105	0.0178	CbGbCtD
Nortriptyline—CYP2C9—Idarubicin—hematologic cancer	0.0104	0.0177	CbGbCtD
Nortriptyline—CYP3A5—Thalidomide—hematologic cancer	0.01	0.017	CbGbCtD
Nortriptyline—CYP3A5—Teniposide—hematologic cancer	0.00955	0.0162	CbGbCtD
Nortriptyline—CYP2D6—Idarubicin—hematologic cancer	0.00952	0.0162	CbGbCtD
Nortriptyline—CYP2C19—Bortezomib—hematologic cancer	0.00926	0.0158	CbGbCtD
Nortriptyline—CYP1A2—Methoxsalen—hematologic cancer	0.00899	0.0153	CbGbCtD
Nortriptyline—CYP3A5—Ifosfamide—hematologic cancer	0.00881	0.015	CbGbCtD
Nortriptyline—CYP2E1—Mitoxantrone—hematologic cancer	0.00859	0.0146	CbGbCtD
Nortriptyline—CYP1A2—Bortezomib—hematologic cancer	0.00855	0.0146	CbGbCtD
Nortriptyline—CYP3A5—Imatinib—hematologic cancer	0.00842	0.0143	CbGbCtD
Nortriptyline—CYP1A2—Daunorubicin—hematologic cancer	0.00818	0.0139	CbGbCtD
Nortriptyline—CYP2D6—Hydroxyurea—hematologic cancer	0.0081	0.0138	CbGbCtD
Nortriptyline—CYP2C19—Thalidomide—hematologic cancer	0.00807	0.0137	CbGbCtD
Nortriptyline—CYP1A2—Alitretinoin—hematologic cancer	0.00801	0.0136	CbGbCtD
Nortriptyline—CYP2C9—Bortezomib—hematologic cancer	0.0077	0.0131	CbGbCtD
Nortriptyline—CYP2C19—Teniposide—hematologic cancer	0.0077	0.0131	CbGbCtD
Nortriptyline—CYP1A2—Thalidomide—hematologic cancer	0.00745	0.0127	CbGbCtD
Nortriptyline—CYP3A4—Bexarotene—hematologic cancer	0.00731	0.0124	CbGbCtD
Nortriptyline—CYP2C19—Ifosfamide—hematologic cancer	0.00711	0.0121	CbGbCtD
Nortriptyline—CYP2D6—Bortezomib—hematologic cancer	0.00704	0.012	CbGbCtD
Nortriptyline—PTGS1—Etoposide—hematologic cancer	0.00701	0.0119	CbGbCtD
Nortriptyline—ALB—Prednisone—hematologic cancer	0.0069	0.0117	CbGbCtD
Nortriptyline—CYP3A4—Lomustine—hematologic cancer	0.00679	0.0116	CbGbCtD
Nortriptyline—CYP3A4—Busulfan—hematologic cancer	0.00679	0.0116	CbGbCtD
Nortriptyline—CYP2C19—Imatinib—hematologic cancer	0.00679	0.0116	CbGbCtD
Nortriptyline—CYP3A5—Dasatinib—hematologic cancer	0.00676	0.0115	CbGbCtD
Nortriptyline—CYP2C9—Thalidomide—hematologic cancer	0.00671	0.0114	CbGbCtD
Nortriptyline—ALB—Irinotecan—hematologic cancer	0.00654	0.0111	CbGbCtD
Nortriptyline—CYP1A2—Dacarbazine—hematologic cancer	0.0064	0.0109	CbGbCtD
Nortriptyline—CYP2C9—Teniposide—hematologic cancer	0.0064	0.0109	CbGbCtD
Nortriptyline—CYP1A2—Imatinib—hematologic cancer	0.00626	0.0107	CbGbCtD
Nortriptyline—CYP3A4—Thiotepa—hematologic cancer	0.00606	0.0103	CbGbCtD
Nortriptyline—CYP2C9—Ifosfamide—hematologic cancer	0.00591	0.0101	CbGbCtD
Nortriptyline—CYP2C9—Imatinib—hematologic cancer	0.00564	0.00961	CbGbCtD
Nortriptyline—CYP2E1—Etoposide—hematologic cancer	0.00542	0.00922	CbGbCtD
Nortriptyline—CYP3A5—Irinotecan—hematologic cancer	0.00526	0.00895	CbGbCtD
Nortriptyline—CYP2D6—Imatinib—hematologic cancer	0.00516	0.00878	CbGbCtD
Nortriptyline—CYP2C9—Nilotinib—hematologic cancer	0.00513	0.00873	CbGbCtD
Nortriptyline—CYP1A2—Dasatinib—hematologic cancer	0.00503	0.00856	CbGbCtD
Nortriptyline—CYP3A4—Methoxsalen—hematologic cancer	0.00471	0.00801	CbGbCtD
Nortriptyline—CYP2D6—Nilotinib—hematologic cancer	0.00469	0.00798	CbGbCtD
Nortriptyline—CYP2D6—Vinorelbine—hematologic cancer	0.00465	0.00791	CbGbCtD
Nortriptyline—CYP3A5—Vincristine—hematologic cancer	0.00459	0.00782	CbGbCtD
Nortriptyline—CYP3A4—Bortezomib—hematologic cancer	0.00448	0.00762	CbGbCtD
Nortriptyline—CYP2C19—Prednisone—hematologic cancer	0.00447	0.00761	CbGbCtD
Nortriptyline—CYP2E1—Dexamethasone—hematologic cancer	0.00445	0.00758	CbGbCtD
Nortriptyline—CYP3A4—Daunorubicin—hematologic cancer	0.00428	0.00729	CbGbCtD
Nortriptyline—CYP3A5—Etoposide—hematologic cancer	0.00421	0.00717	CbGbCtD
Nortriptyline—CYP3A4—Cytarabine—hematologic cancer	0.00378	0.00643	CbGbCtD
Nortriptyline—CYP3A4—Teniposide—hematologic cancer	0.00372	0.00634	CbGbCtD
Nortriptyline—CYP3A5—Dexamethasone—hematologic cancer	0.00346	0.00589	CbGbCtD
Nortriptyline—ALB—Methotrexate—hematologic cancer	0.00346	0.00589	CbGbCtD
Nortriptyline—CYP3A4—Ifosfamide—hematologic cancer	0.00344	0.00585	CbGbCtD
Nortriptyline—CYP3A4—Imatinib—hematologic cancer	0.00328	0.00559	CbGbCtD
Nortriptyline—CYP1A2—Etoposide—hematologic cancer	0.00313	0.00533	CbGbCtD
Nortriptyline—CYP3A4—Ruxolitinib—hematologic cancer	0.00309	0.00526	CbGbCtD
Nortriptyline—CYP3A4—Nilotinib—hematologic cancer	0.00298	0.00508	CbGbCtD
Nortriptyline—CYP3A4—Vinorelbine—hematologic cancer	0.00296	0.00503	CbGbCtD
Nortriptyline—CYP2C9—Cisplatin—hematologic cancer	0.00287	0.00489	CbGbCtD
Nortriptyline—CYP2D6—Vinblastine—hematologic cancer	0.00287	0.00488	CbGbCtD
Nortriptyline—CYP2C19—Dexamethasone—hematologic cancer	0.00279	0.00475	CbGbCtD
Nortriptyline—CYP3A4—Triamcinolone—hematologic cancer	0.0027	0.0046	CbGbCtD
Nortriptyline—CYP3A4—Dasatinib—hematologic cancer	0.00264	0.00449	CbGbCtD
Nortriptyline—CYP3A4—Mitoxantrone—hematologic cancer	0.0026	0.00443	CbGbCtD
Nortriptyline—CYP2C9—Dexamethasone—hematologic cancer	0.00232	0.00395	CbGbCtD
Nortriptyline—CYP3A4—Betamethasone—hematologic cancer	0.00232	0.00395	CbGbCtD
Nortriptyline—CYP3A4—Prednisolone—hematologic cancer	0.00229	0.0039	CbGbCtD
Nortriptyline—CYP3A4—Prednisone—hematologic cancer	0.00216	0.00368	CbGbCtD
Nortriptyline—CYP2D6—Dexamethasone—hematologic cancer	0.00212	0.00361	CbGbCtD
Nortriptyline—CYP3A4—Irinotecan—hematologic cancer	0.00205	0.00349	CbGbCtD
Nortriptyline—CYP3A4—Vinblastine—hematologic cancer	0.00182	0.0031	CbGbCtD
Nortriptyline—CYP3A4—Vincristine—hematologic cancer	0.00179	0.00305	CbGbCtD
Nortriptyline—CYP2D6—Doxorubicin—hematologic cancer	0.00176	0.003	CbGbCtD
Nortriptyline—CYP3A4—Etoposide—hematologic cancer	0.00164	0.00279	CbGbCtD
Nortriptyline—CYP3A4—Dexamethasone—hematologic cancer	0.00135	0.0023	CbGbCtD
Nortriptyline—CYP3A4—Doxorubicin—hematologic cancer	0.00112	0.00191	CbGbCtD
Nortriptyline—ORM1—hematopoietic system—hematologic cancer	0.000801	0.0408	CbGeAlD
Nortriptyline—CHRM4—testis—hematologic cancer	0.000763	0.0388	CbGeAlD
Nortriptyline—SLC6A4—hematopoietic system—hematologic cancer	0.000682	0.0348	CbGeAlD
Nortriptyline—HTR1A—hematopoietic system—hematologic cancer	0.000606	0.0309	CbGeAlD
Nortriptyline—CYP2C19—hematopoietic system—hematologic cancer	0.000565	0.0288	CbGeAlD
Nortriptyline—ADRA1A—hematopoietic system—hematologic cancer	0.000558	0.0284	CbGeAlD
Nortriptyline—ORM1—blood—hematologic cancer	0.000531	0.027	CbGeAlD
Nortriptyline—ORM1—bone marrow—hematologic cancer	0.000513	0.0261	CbGeAlD
Nortriptyline—ORM1—lung—hematologic cancer	0.000465	0.0237	CbGeAlD
Nortriptyline—CYP1A2—hematopoietic system—hematologic cancer	0.000462	0.0235	CbGeAlD
Nortriptyline—SLC6A2—gonad—hematologic cancer	0.000457	0.0233	CbGeAlD
Nortriptyline—SLC6A4—blood—hematologic cancer	0.000452	0.023	CbGeAlD
Nortriptyline—CYP3A5—hematopoietic system—hematologic cancer	0.000445	0.0227	CbGeAlD
Nortriptyline—CYP2C9—hematopoietic system—hematologic cancer	0.000438	0.0223	CbGeAlD
Nortriptyline—HRH1—hematopoietic system—hematologic cancer	0.000432	0.022	CbGeAlD
Nortriptyline—CYP2E1—hematopoietic system—hematologic cancer	0.000415	0.0212	CbGeAlD
Nortriptyline—PTGS1—hematopoietic system—hematologic cancer	0.0004	0.0204	CbGeAlD
Nortriptyline—SLC6A4—lung—hematologic cancer	0.000396	0.0202	CbGeAlD
Nortriptyline—CHRM1—lung—hematologic cancer	0.000395	0.0201	CbGeAlD
Nortriptyline—ALB—testis—hematologic cancer	0.000385	0.0196	CbGeAlD
Nortriptyline—CYP2C19—blood—hematologic cancer	0.000375	0.0191	CbGeAlD
Nortriptyline—ADRA1A—blood—hematologic cancer	0.00037	0.0188	CbGeAlD
Nortriptyline—HTR2A—hematopoietic system—hematologic cancer	0.000361	0.0184	CbGeAlD
Nortriptyline—SLC6A2—lung—hematologic cancer	0.000349	0.0178	CbGeAlD
Nortriptyline—CYP3A4—hematopoietic system—hematologic cancer	0.000334	0.017	CbGeAlD
Nortriptyline—CHRM3—testis—hematologic cancer	0.000333	0.017	CbGeAlD
Nortriptyline—SLC6A2—testis—hematologic cancer	0.000329	0.0168	CbGeAlD
Nortriptyline—CYP2D6—hematopoietic system—hematologic cancer	0.000329	0.0168	CbGeAlD
Nortriptyline—ORM1—lymph node—hematologic cancer	0.000318	0.0162	CbGeAlD
Nortriptyline—DRD2—lung—hematologic cancer	0.000318	0.0162	CbGeAlD
Nortriptyline—CYP1A2—blood—hematologic cancer	0.000306	0.0156	CbGeAlD
Nortriptyline—DRD2—testis—hematologic cancer	0.0003	0.0153	CbGeAlD
Nortriptyline—CYP3A5—blood—hematologic cancer	0.000295	0.015	CbGeAlD
Nortriptyline—CYP2C9—blood—hematologic cancer	0.00029	0.0148	CbGeAlD
Nortriptyline—ALB—lymph node—hematologic cancer	0.000279	0.0142	CbGeAlD
Nortriptyline—CYP2E1—blood—hematologic cancer	0.000275	0.014	CbGeAlD
Nortriptyline—HTR2A—gonad—hematologic cancer	0.000275	0.014	CbGeAlD
Nortriptyline—CYP1A2—lung—hematologic cancer	0.000268	0.0137	CbGeAlD
Nortriptyline—PTGS1—blood—hematologic cancer	0.000265	0.0135	CbGeAlD
Nortriptyline—CYP3A5—lung—hematologic cancer	0.000259	0.0132	CbGeAlD
Nortriptyline—HRH1—lung—hematologic cancer	0.000251	0.0128	CbGeAlD
Nortriptyline—CYP2E1—lung—hematologic cancer	0.000241	0.0123	CbGeAlD
Nortriptyline—HTR2A—blood—hematologic cancer	0.000239	0.0122	CbGeAlD
Nortriptyline—SLC6A2—lymph node—hematologic cancer	0.000239	0.0122	CbGeAlD
Nortriptyline—HRH1—testis—hematologic cancer	0.000237	0.0121	CbGeAlD
Nortriptyline—PTGS1—lung—hematologic cancer	0.000232	0.0118	CbGeAlD
Nortriptyline—CYP2E1—testis—hematologic cancer	0.000228	0.0116	CbGeAlD
Nortriptyline—CYP3A4—blood—hematologic cancer	0.000221	0.0113	CbGeAlD
Nortriptyline—PTGS1—testis—hematologic cancer	0.000219	0.0112	CbGeAlD
Nortriptyline—CYP2D6—blood—hematologic cancer	0.000218	0.0111	CbGeAlD
Nortriptyline—HTR2A—lung—hematologic cancer	0.00021	0.0107	CbGeAlD
Nortriptyline—HTR2A—testis—hematologic cancer	0.000198	0.0101	CbGeAlD
Nortriptyline—CYP2D6—testis—hematologic cancer	0.00018	0.00918	CbGeAlD
Nortriptyline—HRH1—lymph node—hematologic cancer	0.000172	0.00875	CbGeAlD
Nortriptyline—PTGS1—lymph node—hematologic cancer	0.000159	0.0081	CbGeAlD
Nortriptyline—Clomipramine—GSTP1—hematologic cancer	0.000155	0.152	CrCbGaD
Nortriptyline—Desipramine—SLC22A1—hematologic cancer	0.000116	0.113	CrCbGaD
Nortriptyline—Protriptyline—ABCB1—hematologic cancer	0.000106	0.104	CrCbGaD
Nortriptyline—Imipramine—SLC22A1—hematologic cancer	9.8e-05	0.096	CrCbGaD
Nortriptyline—Epinastine—ABCB1—hematologic cancer	7.89e-05	0.0773	CrCbGaD
Nortriptyline—Oxcarbazepine—ALB—hematologic cancer	7.62e-05	0.0747	CrCbGaD
Nortriptyline—Maprotiline—ABCB1—hematologic cancer	6.79e-05	0.0666	CrCbGaD
Nortriptyline—Clomipramine—ALB—hematologic cancer	4.37e-05	0.0429	CrCbGaD
Nortriptyline—Clomipramine—ABCB1—hematologic cancer	4.17e-05	0.0409	CrCbGaD
Nortriptyline—Chlorprothixene—ABCB1—hematologic cancer	4.16e-05	0.0407	CrCbGaD
Nortriptyline—Trimipramine—ABCB1—hematologic cancer	3.84e-05	0.0376	CrCbGaD
Nortriptyline—Doxepin—ABCB1—hematologic cancer	3.66e-05	0.0359	CrCbGaD
Nortriptyline—Convulsion—Prednisone—hematologic cancer	3.5e-05	0.000148	CcSEcCtD
Nortriptyline—Agranulocytosis—Doxorubicin—hematologic cancer	3.49e-05	0.000148	CcSEcCtD
Nortriptyline—Hypertension—Prednisone—hematologic cancer	3.48e-05	0.000147	CcSEcCtD
Nortriptyline—Rash—Irinotecan—hematologic cancer	3.48e-05	0.000147	CcSEcCtD
Nortriptyline—Rash—Mitoxantrone—hematologic cancer	3.48e-05	0.000147	CcSEcCtD
Nortriptyline—Dermatitis—Irinotecan—hematologic cancer	3.48e-05	0.000147	CcSEcCtD
Nortriptyline—Dermatitis—Mitoxantrone—hematologic cancer	3.48e-05	0.000147	CcSEcCtD
Nortriptyline—Headache—Irinotecan—hematologic cancer	3.46e-05	0.000146	CcSEcCtD
Nortriptyline—Headache—Mitoxantrone—hematologic cancer	3.46e-05	0.000146	CcSEcCtD
Nortriptyline—Nausea—Ifosfamide—hematologic cancer	3.46e-05	0.000146	CcSEcCtD
Nortriptyline—Feeling abnormal—Triamcinolone—hematologic cancer	3.43e-05	0.000145	CcSEcCtD
Nortriptyline—Diarrhoea—Cisplatin—hematologic cancer	3.43e-05	0.000145	CcSEcCtD
Nortriptyline—Anxiety—Prednisone—hematologic cancer	3.42e-05	0.000145	CcSEcCtD
Nortriptyline—Alopecia—Methotrexate—hematologic cancer	3.42e-05	0.000145	CcSEcCtD
Nortriptyline—Vomiting—Gemcitabine—hematologic cancer	3.42e-05	0.000145	CcSEcCtD
Nortriptyline—Insomnia—Dexamethasone—hematologic cancer	3.42e-05	0.000145	CcSEcCtD
Nortriptyline—Insomnia—Betamethasone—hematologic cancer	3.42e-05	0.000145	CcSEcCtD
Nortriptyline—Paraesthesia—Dexamethasone—hematologic cancer	3.4e-05	0.000144	CcSEcCtD
Nortriptyline—Paraesthesia—Betamethasone—hematologic cancer	3.4e-05	0.000144	CcSEcCtD
Nortriptyline—Discomfort—Prednisone—hematologic cancer	3.39e-05	0.000144	CcSEcCtD
Nortriptyline—Rash—Gemcitabine—hematologic cancer	3.39e-05	0.000144	CcSEcCtD
Nortriptyline—Dermatitis—Gemcitabine—hematologic cancer	3.39e-05	0.000143	CcSEcCtD
Nortriptyline—Eye disorder—Epirubicin—hematologic cancer	3.39e-05	0.000143	CcSEcCtD
Nortriptyline—Hypersensitivity—Etoposide—hematologic cancer	3.39e-05	0.000143	CcSEcCtD
Nortriptyline—Tinnitus—Epirubicin—hematologic cancer	3.38e-05	0.000143	CcSEcCtD
Nortriptyline—Headache—Gemcitabine—hematologic cancer	3.37e-05	0.000143	CcSEcCtD
Nortriptyline—Nausea—Vincristine—hematologic cancer	3.37e-05	0.000143	CcSEcCtD
Nortriptyline—Flushing—Epirubicin—hematologic cancer	3.37e-05	0.000142	CcSEcCtD
Nortriptyline—Desipramine—ABCB1—hematologic cancer	3.36e-05	0.0329	CrCbGaD
Nortriptyline—Hepatitis—Doxorubicin—hematologic cancer	3.35e-05	0.000142	CcSEcCtD
Nortriptyline—Hypersensitivity—Prednisolone—hematologic cancer	3.34e-05	0.000141	CcSEcCtD
Nortriptyline—Hypoaesthesia—Doxorubicin—hematologic cancer	3.34e-05	0.000141	CcSEcCtD
Nortriptyline—Dyspepsia—Betamethasone—hematologic cancer	3.33e-05	0.000141	CcSEcCtD
Nortriptyline—Dyspepsia—Dexamethasone—hematologic cancer	3.33e-05	0.000141	CcSEcCtD
Nortriptyline—Urticaria—Triamcinolone—hematologic cancer	3.31e-05	0.00014	CcSEcCtD
Nortriptyline—Oedema peripheral—Doxorubicin—hematologic cancer	3.31e-05	0.00014	CcSEcCtD
Nortriptyline—Dysgeusia—Methotrexate—hematologic cancer	3.3e-05	0.00014	CcSEcCtD
Nortriptyline—Asthenia—Etoposide—hematologic cancer	3.3e-05	0.00014	CcSEcCtD
Nortriptyline—Body temperature increased—Triamcinolone—hematologic cancer	3.3e-05	0.000139	CcSEcCtD
Nortriptyline—Oedema—Prednisone—hematologic cancer	3.29e-05	0.000139	CcSEcCtD
Nortriptyline—Decreased appetite—Dexamethasone—hematologic cancer	3.29e-05	0.000139	CcSEcCtD
Nortriptyline—Decreased appetite—Betamethasone—hematologic cancer	3.29e-05	0.000139	CcSEcCtD
Nortriptyline—Nausea—Irinotecan—hematologic cancer	3.28e-05	0.000139	CcSEcCtD
Nortriptyline—Nausea—Mitoxantrone—hematologic cancer	3.28e-05	0.000139	CcSEcCtD
Nortriptyline—Fatigue—Betamethasone—hematologic cancer	3.26e-05	0.000138	CcSEcCtD
Nortriptyline—Fatigue—Dexamethasone—hematologic cancer	3.26e-05	0.000138	CcSEcCtD
Nortriptyline—Pruritus—Etoposide—hematologic cancer	3.25e-05	0.000138	CcSEcCtD
Nortriptyline—Shock—Prednisone—hematologic cancer	3.24e-05	0.000137	CcSEcCtD
Nortriptyline—Arrhythmia—Epirubicin—hematologic cancer	3.24e-05	0.000137	CcSEcCtD
Nortriptyline—Tachycardia—Prednisone—hematologic cancer	3.21e-05	0.000136	CcSEcCtD
Nortriptyline—Alopecia—Epirubicin—hematologic cancer	3.2e-05	0.000136	CcSEcCtD
Nortriptyline—Nausea—Gemcitabine—hematologic cancer	3.2e-05	0.000135	CcSEcCtD
Nortriptyline—Vomiting—Cisplatin—hematologic cancer	3.19e-05	0.000135	CcSEcCtD
Nortriptyline—Hyperhidrosis—Prednisone—hematologic cancer	3.18e-05	0.000135	CcSEcCtD
Nortriptyline—Vision blurred—Methotrexate—hematologic cancer	3.18e-05	0.000135	CcSEcCtD
Nortriptyline—Rash—Cisplatin—hematologic cancer	3.16e-05	0.000134	CcSEcCtD
Nortriptyline—Dermatitis—Cisplatin—hematologic cancer	3.16e-05	0.000134	CcSEcCtD
Nortriptyline—Diarrhoea—Etoposide—hematologic cancer	3.14e-05	0.000133	CcSEcCtD
Nortriptyline—Anorexia—Prednisone—hematologic cancer	3.14e-05	0.000133	CcSEcCtD
Nortriptyline—Eye disorder—Doxorubicin—hematologic cancer	3.14e-05	0.000133	CcSEcCtD
Nortriptyline—Ill-defined disorder—Methotrexate—hematologic cancer	3.13e-05	0.000132	CcSEcCtD
Nortriptyline—Tinnitus—Doxorubicin—hematologic cancer	3.13e-05	0.000132	CcSEcCtD
Nortriptyline—Feeling abnormal—Dexamethasone—hematologic cancer	3.12e-05	0.000132	CcSEcCtD
Nortriptyline—Feeling abnormal—Betamethasone—hematologic cancer	3.12e-05	0.000132	CcSEcCtD
Nortriptyline—Flushing—Doxorubicin—hematologic cancer	3.11e-05	0.000132	CcSEcCtD
Nortriptyline—Tension—Epirubicin—hematologic cancer	3.1e-05	0.000131	CcSEcCtD
Nortriptyline—Dysgeusia—Epirubicin—hematologic cancer	3.09e-05	0.000131	CcSEcCtD
Nortriptyline—Hypersensitivity—Triamcinolone—hematologic cancer	3.07e-05	0.00013	CcSEcCtD
Nortriptyline—Nervousness—Epirubicin—hematologic cancer	3.07e-05	0.00013	CcSEcCtD
Nortriptyline—Malaise—Methotrexate—hematologic cancer	3.04e-05	0.000129	CcSEcCtD
Nortriptyline—Dizziness—Etoposide—hematologic cancer	3.04e-05	0.000129	CcSEcCtD
Nortriptyline—Leukopenia—Methotrexate—hematologic cancer	3.02e-05	0.000128	CcSEcCtD
Nortriptyline—Urticaria—Dexamethasone—hematologic cancer	3e-05	0.000127	CcSEcCtD
Nortriptyline—Urticaria—Betamethasone—hematologic cancer	3e-05	0.000127	CcSEcCtD
Nortriptyline—Dizziness—Prednisolone—hematologic cancer	3e-05	0.000127	CcSEcCtD
Nortriptyline—Arrhythmia—Doxorubicin—hematologic cancer	3e-05	0.000127	CcSEcCtD
Nortriptyline—Asthenia—Triamcinolone—hematologic cancer	2.99e-05	0.000127	CcSEcCtD
Nortriptyline—Abdominal pain—Dexamethasone—hematologic cancer	2.99e-05	0.000127	CcSEcCtD
Nortriptyline—Body temperature increased—Betamethasone—hematologic cancer	2.99e-05	0.000127	CcSEcCtD
Nortriptyline—Body temperature increased—Dexamethasone—hematologic cancer	2.99e-05	0.000127	CcSEcCtD
Nortriptyline—Abdominal pain—Betamethasone—hematologic cancer	2.99e-05	0.000127	CcSEcCtD
Nortriptyline—Nausea—Cisplatin—hematologic cancer	2.98e-05	0.000126	CcSEcCtD
Nortriptyline—Insomnia—Prednisone—hematologic cancer	2.98e-05	0.000126	CcSEcCtD
Nortriptyline—Vision blurred—Epirubicin—hematologic cancer	2.97e-05	0.000126	CcSEcCtD
Nortriptyline—Amitriptyline—ALB—hematologic cancer	2.97e-05	0.0291	CrCbGaD
Nortriptyline—Alopecia—Doxorubicin—hematologic cancer	2.96e-05	0.000125	CcSEcCtD
Nortriptyline—Paraesthesia—Prednisone—hematologic cancer	2.96e-05	0.000125	CcSEcCtD
Nortriptyline—Pruritus—Triamcinolone—hematologic cancer	2.95e-05	0.000125	CcSEcCtD
Nortriptyline—Ill-defined disorder—Epirubicin—hematologic cancer	2.93e-05	0.000124	CcSEcCtD
Nortriptyline—Convulsion—Methotrexate—hematologic cancer	2.92e-05	0.000124	CcSEcCtD
Nortriptyline—Vomiting—Etoposide—hematologic cancer	2.92e-05	0.000124	CcSEcCtD
Nortriptyline—Agitation—Epirubicin—hematologic cancer	2.9e-05	0.000123	CcSEcCtD
Nortriptyline—Dyspepsia—Prednisone—hematologic cancer	2.9e-05	0.000123	CcSEcCtD
Nortriptyline—Rash—Etoposide—hematologic cancer	2.9e-05	0.000123	CcSEcCtD
Nortriptyline—Dermatitis—Etoposide—hematologic cancer	2.89e-05	0.000123	CcSEcCtD
Nortriptyline—Headache—Etoposide—hematologic cancer	2.88e-05	0.000122	CcSEcCtD
Nortriptyline—Tension—Doxorubicin—hematologic cancer	2.87e-05	0.000121	CcSEcCtD
Nortriptyline—Decreased appetite—Prednisone—hematologic cancer	2.86e-05	0.000121	CcSEcCtD
Nortriptyline—Dysgeusia—Doxorubicin—hematologic cancer	2.86e-05	0.000121	CcSEcCtD
Nortriptyline—Rash—Prednisolone—hematologic cancer	2.86e-05	0.000121	CcSEcCtD
Nortriptyline—Dermatitis—Prednisolone—hematologic cancer	2.86e-05	0.000121	CcSEcCtD
Nortriptyline—Imipramine—ABCB1—hematologic cancer	2.85e-05	0.0279	CrCbGaD
Nortriptyline—Malaise—Epirubicin—hematologic cancer	2.85e-05	0.00012	CcSEcCtD
Nortriptyline—Fatigue—Prednisone—hematologic cancer	2.84e-05	0.00012	CcSEcCtD
Nortriptyline—Headache—Prednisolone—hematologic cancer	2.84e-05	0.00012	CcSEcCtD
Nortriptyline—Discomfort—Methotrexate—hematologic cancer	2.84e-05	0.00012	CcSEcCtD
Nortriptyline—Nervousness—Doxorubicin—hematologic cancer	2.84e-05	0.00012	CcSEcCtD
Nortriptyline—Amitriptyline—ABCB1—hematologic cancer	2.83e-05	0.0277	CrCbGaD
Nortriptyline—Syncope—Epirubicin—hematologic cancer	2.83e-05	0.00012	CcSEcCtD
Nortriptyline—Leukopenia—Epirubicin—hematologic cancer	2.83e-05	0.00012	CcSEcCtD
Nortriptyline—Constipation—Prednisone—hematologic cancer	2.82e-05	0.000119	CcSEcCtD
Nortriptyline—Palpitations—Epirubicin—hematologic cancer	2.79e-05	0.000118	CcSEcCtD
Nortriptyline—Confusional state—Methotrexate—hematologic cancer	2.78e-05	0.000117	CcSEcCtD
Nortriptyline—Loss of consciousness—Epirubicin—hematologic cancer	2.77e-05	0.000117	CcSEcCtD
Nortriptyline—Dizziness—Triamcinolone—hematologic cancer	2.76e-05	0.000117	CcSEcCtD
Nortriptyline—Vision blurred—Doxorubicin—hematologic cancer	2.75e-05	0.000116	CcSEcCtD
Nortriptyline—Convulsion—Epirubicin—hematologic cancer	2.73e-05	0.000116	CcSEcCtD
Nortriptyline—Nausea—Etoposide—hematologic cancer	2.73e-05	0.000116	CcSEcCtD
Nortriptyline—Hypertension—Epirubicin—hematologic cancer	2.73e-05	0.000115	CcSEcCtD
Nortriptyline—Feeling abnormal—Prednisone—hematologic cancer	2.71e-05	0.000115	CcSEcCtD
Nortriptyline—Asthenia—Dexamethasone—hematologic cancer	2.71e-05	0.000115	CcSEcCtD
Nortriptyline—Asthenia—Betamethasone—hematologic cancer	2.71e-05	0.000115	CcSEcCtD
Nortriptyline—Ill-defined disorder—Doxorubicin—hematologic cancer	2.71e-05	0.000115	CcSEcCtD
Nortriptyline—Thrombocytopenia—Methotrexate—hematologic cancer	2.7e-05	0.000114	CcSEcCtD
Nortriptyline—Nausea—Prednisolone—hematologic cancer	2.69e-05	0.000114	CcSEcCtD
Nortriptyline—Agitation—Doxorubicin—hematologic cancer	2.68e-05	0.000114	CcSEcCtD
Nortriptyline—Anxiety—Epirubicin—hematologic cancer	2.68e-05	0.000113	CcSEcCtD
Nortriptyline—Pruritus—Betamethasone—hematologic cancer	2.68e-05	0.000113	CcSEcCtD
Nortriptyline—Pruritus—Dexamethasone—hematologic cancer	2.68e-05	0.000113	CcSEcCtD
Nortriptyline—Hyperhidrosis—Methotrexate—hematologic cancer	2.66e-05	0.000113	CcSEcCtD
Nortriptyline—Discomfort—Epirubicin—hematologic cancer	2.66e-05	0.000112	CcSEcCtD
Nortriptyline—Vomiting—Triamcinolone—hematologic cancer	2.65e-05	0.000112	CcSEcCtD
Nortriptyline—Malaise—Doxorubicin—hematologic cancer	2.63e-05	0.000111	CcSEcCtD
Nortriptyline—Rash—Triamcinolone—hematologic cancer	2.63e-05	0.000111	CcSEcCtD
Nortriptyline—Dry mouth—Epirubicin—hematologic cancer	2.63e-05	0.000111	CcSEcCtD
Nortriptyline—Dermatitis—Triamcinolone—hematologic cancer	2.63e-05	0.000111	CcSEcCtD
Nortriptyline—Anorexia—Methotrexate—hematologic cancer	2.62e-05	0.000111	CcSEcCtD
Nortriptyline—Syncope—Doxorubicin—hematologic cancer	2.62e-05	0.000111	CcSEcCtD
Nortriptyline—Urticaria—Prednisone—hematologic cancer	2.62e-05	0.000111	CcSEcCtD
Nortriptyline—Leukopenia—Doxorubicin—hematologic cancer	2.61e-05	0.000111	CcSEcCtD
Nortriptyline—Headache—Triamcinolone—hematologic cancer	2.61e-05	0.000111	CcSEcCtD
Nortriptyline—Abdominal pain—Prednisone—hematologic cancer	2.6e-05	0.00011	CcSEcCtD
Nortriptyline—Body temperature increased—Prednisone—hematologic cancer	2.6e-05	0.00011	CcSEcCtD
Nortriptyline—Confusional state—Epirubicin—hematologic cancer	2.6e-05	0.00011	CcSEcCtD
Nortriptyline—Diarrhoea—Betamethasone—hematologic cancer	2.59e-05	0.00011	CcSEcCtD
Nortriptyline—Diarrhoea—Dexamethasone—hematologic cancer	2.59e-05	0.00011	CcSEcCtD
Nortriptyline—Palpitations—Doxorubicin—hematologic cancer	2.58e-05	0.000109	CcSEcCtD
Nortriptyline—Oedema—Epirubicin—hematologic cancer	2.58e-05	0.000109	CcSEcCtD
Nortriptyline—Hypotension—Methotrexate—hematologic cancer	2.57e-05	0.000109	CcSEcCtD
Nortriptyline—Loss of consciousness—Doxorubicin—hematologic cancer	2.57e-05	0.000109	CcSEcCtD
Nortriptyline—Shock—Epirubicin—hematologic cancer	2.53e-05	0.000107	CcSEcCtD
Nortriptyline—Convulsion—Doxorubicin—hematologic cancer	2.53e-05	0.000107	CcSEcCtD
Nortriptyline—Thrombocytopenia—Epirubicin—hematologic cancer	2.52e-05	0.000107	CcSEcCtD
Nortriptyline—Hypertension—Doxorubicin—hematologic cancer	2.52e-05	0.000107	CcSEcCtD
Nortriptyline—Tachycardia—Epirubicin—hematologic cancer	2.51e-05	0.000106	CcSEcCtD
Nortriptyline—Dizziness—Betamethasone—hematologic cancer	2.5e-05	0.000106	CcSEcCtD
Nortriptyline—Dizziness—Dexamethasone—hematologic cancer	2.5e-05	0.000106	CcSEcCtD
Nortriptyline—Hyperhidrosis—Epirubicin—hematologic cancer	2.49e-05	0.000105	CcSEcCtD
Nortriptyline—Insomnia—Methotrexate—hematologic cancer	2.49e-05	0.000105	CcSEcCtD
Nortriptyline—Anxiety—Doxorubicin—hematologic cancer	2.48e-05	0.000105	CcSEcCtD
Nortriptyline—Nausea—Triamcinolone—hematologic cancer	2.48e-05	0.000105	CcSEcCtD
Nortriptyline—Paraesthesia—Methotrexate—hematologic cancer	2.47e-05	0.000105	CcSEcCtD
Nortriptyline—Discomfort—Doxorubicin—hematologic cancer	2.46e-05	0.000104	CcSEcCtD
Nortriptyline—Anorexia—Epirubicin—hematologic cancer	2.46e-05	0.000104	CcSEcCtD
Nortriptyline—Somnolence—Methotrexate—hematologic cancer	2.45e-05	0.000104	CcSEcCtD
Nortriptyline—Dry mouth—Doxorubicin—hematologic cancer	2.43e-05	0.000103	CcSEcCtD
Nortriptyline—Hypersensitivity—Prednisone—hematologic cancer	2.43e-05	0.000103	CcSEcCtD
Nortriptyline—Dyspepsia—Methotrexate—hematologic cancer	2.42e-05	0.000103	CcSEcCtD
Nortriptyline—Hypotension—Epirubicin—hematologic cancer	2.41e-05	0.000102	CcSEcCtD
Nortriptyline—Vomiting—Dexamethasone—hematologic cancer	2.4e-05	0.000102	CcSEcCtD
Nortriptyline—Vomiting—Betamethasone—hematologic cancer	2.4e-05	0.000102	CcSEcCtD
Nortriptyline—Confusional state—Doxorubicin—hematologic cancer	2.4e-05	0.000102	CcSEcCtD
Nortriptyline—Decreased appetite—Methotrexate—hematologic cancer	2.39e-05	0.000101	CcSEcCtD
Nortriptyline—Rash—Dexamethasone—hematologic cancer	2.38e-05	0.000101	CcSEcCtD
Nortriptyline—Rash—Betamethasone—hematologic cancer	2.38e-05	0.000101	CcSEcCtD
Nortriptyline—Oedema—Doxorubicin—hematologic cancer	2.38e-05	0.000101	CcSEcCtD
Nortriptyline—Dermatitis—Betamethasone—hematologic cancer	2.38e-05	0.000101	CcSEcCtD
Nortriptyline—Dermatitis—Dexamethasone—hematologic cancer	2.38e-05	0.000101	CcSEcCtD
Nortriptyline—Fatigue—Methotrexate—hematologic cancer	2.37e-05	0.0001	CcSEcCtD
Nortriptyline—Headache—Dexamethasone—hematologic cancer	2.37e-05	0.0001	CcSEcCtD
Nortriptyline—Headache—Betamethasone—hematologic cancer	2.37e-05	0.0001	CcSEcCtD
Nortriptyline—Asthenia—Prednisone—hematologic cancer	2.36e-05	0.0001	CcSEcCtD
Nortriptyline—Shock—Doxorubicin—hematologic cancer	2.35e-05	9.92e-05	CcSEcCtD
Nortriptyline—Thrombocytopenia—Doxorubicin—hematologic cancer	2.33e-05	9.88e-05	CcSEcCtD
Nortriptyline—Pruritus—Prednisone—hematologic cancer	2.33e-05	9.86e-05	CcSEcCtD
Nortriptyline—Insomnia—Epirubicin—hematologic cancer	2.33e-05	9.86e-05	CcSEcCtD
Nortriptyline—Tachycardia—Doxorubicin—hematologic cancer	2.33e-05	9.85e-05	CcSEcCtD
Nortriptyline—Paraesthesia—Epirubicin—hematologic cancer	2.31e-05	9.79e-05	CcSEcCtD
Nortriptyline—Hyperhidrosis—Doxorubicin—hematologic cancer	2.3e-05	9.75e-05	CcSEcCtD
Nortriptyline—Somnolence—Epirubicin—hematologic cancer	2.29e-05	9.69e-05	CcSEcCtD
Nortriptyline—Anorexia—Doxorubicin—hematologic cancer	2.27e-05	9.62e-05	CcSEcCtD
Nortriptyline—Feeling abnormal—Methotrexate—hematologic cancer	2.27e-05	9.6e-05	CcSEcCtD
Nortriptyline—Dyspepsia—Epirubicin—hematologic cancer	2.27e-05	9.6e-05	CcSEcCtD
Nortriptyline—Diarrhoea—Prednisone—hematologic cancer	2.25e-05	9.54e-05	CcSEcCtD
Nortriptyline—Nausea—Dexamethasone—hematologic cancer	2.25e-05	9.51e-05	CcSEcCtD
Nortriptyline—Nausea—Betamethasone—hematologic cancer	2.25e-05	9.51e-05	CcSEcCtD
Nortriptyline—Decreased appetite—Epirubicin—hematologic cancer	2.24e-05	9.48e-05	CcSEcCtD
Nortriptyline—Hypotension—Doxorubicin—hematologic cancer	2.23e-05	9.43e-05	CcSEcCtD
Nortriptyline—Fatigue—Epirubicin—hematologic cancer	2.22e-05	9.4e-05	CcSEcCtD
Nortriptyline—Constipation—Epirubicin—hematologic cancer	2.2e-05	9.32e-05	CcSEcCtD
Nortriptyline—Urticaria—Methotrexate—hematologic cancer	2.19e-05	9.25e-05	CcSEcCtD
Nortriptyline—Dizziness—Prednisone—hematologic cancer	2.18e-05	9.22e-05	CcSEcCtD
Nortriptyline—Abdominal pain—Methotrexate—hematologic cancer	2.18e-05	9.21e-05	CcSEcCtD
Nortriptyline—Body temperature increased—Methotrexate—hematologic cancer	2.18e-05	9.21e-05	CcSEcCtD
Nortriptyline—Insomnia—Doxorubicin—hematologic cancer	2.16e-05	9.12e-05	CcSEcCtD
Nortriptyline—Paraesthesia—Doxorubicin—hematologic cancer	2.14e-05	9.06e-05	CcSEcCtD
Nortriptyline—Feeling abnormal—Epirubicin—hematologic cancer	2.12e-05	8.98e-05	CcSEcCtD
Nortriptyline—Somnolence—Doxorubicin—hematologic cancer	2.12e-05	8.97e-05	CcSEcCtD
Nortriptyline—Dyspepsia—Doxorubicin—hematologic cancer	2.1e-05	8.88e-05	CcSEcCtD
Nortriptyline—Vomiting—Prednisone—hematologic cancer	2.09e-05	8.86e-05	CcSEcCtD
Nortriptyline—Rash—Prednisone—hematologic cancer	2.08e-05	8.79e-05	CcSEcCtD
Nortriptyline—Dermatitis—Prednisone—hematologic cancer	2.07e-05	8.78e-05	CcSEcCtD
Nortriptyline—Decreased appetite—Doxorubicin—hematologic cancer	2.07e-05	8.77e-05	CcSEcCtD
Nortriptyline—Headache—Prednisone—hematologic cancer	2.06e-05	8.73e-05	CcSEcCtD
Nortriptyline—Fatigue—Doxorubicin—hematologic cancer	2.05e-05	8.7e-05	CcSEcCtD
Nortriptyline—Urticaria—Epirubicin—hematologic cancer	2.05e-05	8.66e-05	CcSEcCtD
Nortriptyline—Constipation—Doxorubicin—hematologic cancer	2.04e-05	8.63e-05	CcSEcCtD
Nortriptyline—Abdominal pain—Epirubicin—hematologic cancer	2.04e-05	8.62e-05	CcSEcCtD
Nortriptyline—Body temperature increased—Epirubicin—hematologic cancer	2.04e-05	8.62e-05	CcSEcCtD
Nortriptyline—Hypersensitivity—Methotrexate—hematologic cancer	2.03e-05	8.58e-05	CcSEcCtD
Nortriptyline—Asthenia—Methotrexate—hematologic cancer	1.97e-05	8.36e-05	CcSEcCtD
Nortriptyline—Feeling abnormal—Doxorubicin—hematologic cancer	1.96e-05	8.31e-05	CcSEcCtD
Nortriptyline—Nausea—Prednisone—hematologic cancer	1.96e-05	8.28e-05	CcSEcCtD
Nortriptyline—Pruritus—Methotrexate—hematologic cancer	1.95e-05	8.24e-05	CcSEcCtD
Nortriptyline—Hypersensitivity—Epirubicin—hematologic cancer	1.9e-05	8.03e-05	CcSEcCtD
Nortriptyline—Urticaria—Doxorubicin—hematologic cancer	1.89e-05	8.01e-05	CcSEcCtD
Nortriptyline—Body temperature increased—Doxorubicin—hematologic cancer	1.88e-05	7.97e-05	CcSEcCtD
Nortriptyline—Abdominal pain—Doxorubicin—hematologic cancer	1.88e-05	7.97e-05	CcSEcCtD
Nortriptyline—Diarrhoea—Methotrexate—hematologic cancer	1.88e-05	7.97e-05	CcSEcCtD
Nortriptyline—Asthenia—Epirubicin—hematologic cancer	1.85e-05	7.82e-05	CcSEcCtD
Nortriptyline—Pruritus—Epirubicin—hematologic cancer	1.82e-05	7.71e-05	CcSEcCtD
Nortriptyline—Dizziness—Methotrexate—hematologic cancer	1.82e-05	7.7e-05	CcSEcCtD
Nortriptyline—Diarrhoea—Epirubicin—hematologic cancer	1.76e-05	7.46e-05	CcSEcCtD
Nortriptyline—Hypersensitivity—Doxorubicin—hematologic cancer	1.76e-05	7.43e-05	CcSEcCtD
Nortriptyline—Vomiting—Methotrexate—hematologic cancer	1.75e-05	7.41e-05	CcSEcCtD
Nortriptyline—Rash—Methotrexate—hematologic cancer	1.74e-05	7.35e-05	CcSEcCtD
Nortriptyline—Dermatitis—Methotrexate—hematologic cancer	1.73e-05	7.34e-05	CcSEcCtD
Nortriptyline—Headache—Methotrexate—hematologic cancer	1.72e-05	7.3e-05	CcSEcCtD
Nortriptyline—Asthenia—Doxorubicin—hematologic cancer	1.71e-05	7.24e-05	CcSEcCtD
Nortriptyline—Dizziness—Epirubicin—hematologic cancer	1.7e-05	7.21e-05	CcSEcCtD
Nortriptyline—Pruritus—Doxorubicin—hematologic cancer	1.69e-05	7.14e-05	CcSEcCtD
Nortriptyline—Vomiting—Epirubicin—hematologic cancer	1.64e-05	6.93e-05	CcSEcCtD
Nortriptyline—Nausea—Methotrexate—hematologic cancer	1.64e-05	6.92e-05	CcSEcCtD
Nortriptyline—Diarrhoea—Doxorubicin—hematologic cancer	1.63e-05	6.9e-05	CcSEcCtD
Nortriptyline—Rash—Epirubicin—hematologic cancer	1.62e-05	6.87e-05	CcSEcCtD
Nortriptyline—Dermatitis—Epirubicin—hematologic cancer	1.62e-05	6.87e-05	CcSEcCtD
Nortriptyline—Headache—Epirubicin—hematologic cancer	1.61e-05	6.83e-05	CcSEcCtD
Nortriptyline—Dizziness—Doxorubicin—hematologic cancer	1.58e-05	6.67e-05	CcSEcCtD
Nortriptyline—Nausea—Epirubicin—hematologic cancer	1.53e-05	6.48e-05	CcSEcCtD
Nortriptyline—Vomiting—Doxorubicin—hematologic cancer	1.52e-05	6.41e-05	CcSEcCtD
Nortriptyline—Rash—Doxorubicin—hematologic cancer	1.5e-05	6.36e-05	CcSEcCtD
Nortriptyline—Dermatitis—Doxorubicin—hematologic cancer	1.5e-05	6.35e-05	CcSEcCtD
Nortriptyline—Headache—Doxorubicin—hematologic cancer	1.49e-05	6.32e-05	CcSEcCtD
Nortriptyline—Nausea—Doxorubicin—hematologic cancer	1.42e-05	5.99e-05	CcSEcCtD
Nortriptyline—CHRM3—Signaling Pathways—CCND1—hematologic cancer	1.63e-06	1.61e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.62e-06	1.61e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—JUN—hematologic cancer	1.62e-06	1.61e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.62e-06	1.6e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—SRC—hematologic cancer	1.62e-06	1.6e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—HRAS—hematologic cancer	1.62e-06	1.6e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—KRAS—hematologic cancer	1.61e-06	1.6e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	1.61e-06	1.6e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCND1—hematologic cancer	1.61e-06	1.59e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PTEN—hematologic cancer	1.61e-06	1.59e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—JUN—hematologic cancer	1.61e-06	1.59e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCND1—hematologic cancer	1.61e-06	1.59e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—JUN—hematologic cancer	1.6e-06	1.59e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ALB—hematologic cancer	1.6e-06	1.58e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TP53—hematologic cancer	1.59e-06	1.58e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CDKN1A—hematologic cancer	1.59e-06	1.57e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	1.58e-06	1.57e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PTEN—hematologic cancer	1.58e-06	1.57e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PTEN—hematologic cancer	1.58e-06	1.56e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PTEN—hematologic cancer	1.58e-06	1.56e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PTEN—hematologic cancer	1.58e-06	1.56e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	1.58e-06	1.56e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—PIK3CA—hematologic cancer	1.58e-06	1.56e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—VEGFA—hematologic cancer	1.58e-06	1.56e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PTEN—hematologic cancer	1.57e-06	1.56e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MAPK8—hematologic cancer	1.57e-06	1.56e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CDKN1A—hematologic cancer	1.57e-06	1.56e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PIK3CB—hematologic cancer	1.57e-06	1.56e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.57e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—AKT1—hematologic cancer	1.57e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PTEN—hematologic cancer	1.57e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	1.57e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—STAT3—hematologic cancer	1.56e-06	1.54e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.56e-06	1.54e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	1.56e-06	1.54e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MAPK3—hematologic cancer	1.56e-06	1.54e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NRAS—hematologic cancer	1.56e-06	1.54e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PTEN—hematologic cancer	1.55e-06	1.54e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	1.55e-06	1.54e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	1.55e-06	1.53e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MAPK8—hematologic cancer	1.55e-06	1.53e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6—hematologic cancer	1.55e-06	1.53e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MAPK8—hematologic cancer	1.54e-06	1.53e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	1.54e-06	1.53e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—AKT1—hematologic cancer	1.54e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	1.54e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.54e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	1.54e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	1.54e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EP300—hematologic cancer	1.53e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	1.53e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.53e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TP53—hematologic cancer	1.53e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—HRAS—hematologic cancer	1.52e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MYC—hematologic cancer	1.52e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	1.52e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	1.52e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	1.52e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	1.52e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MYC—hematologic cancer	1.51e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	1.51e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TGFB1—hematologic cancer	1.51e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EP300—hematologic cancer	1.51e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—EP300—hematologic cancer	1.51e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EP300—hematologic cancer	1.51e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.51e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—EP300—hematologic cancer	1.5e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EP300—hematologic cancer	1.5e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EP300—hematologic cancer	1.5e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PIK3CA—hematologic cancer	1.49e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.49e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.49e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—SRC—hematologic cancer	1.49e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MAPK3—hematologic cancer	1.49e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.49e-06	1.47e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—PIK3CA—hematologic cancer	1.48e-06	1.47e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EP300—hematologic cancer	1.48e-06	1.47e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EP300—hematologic cancer	1.48e-06	1.46e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.48e-06	1.46e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ALB—hematologic cancer	1.47e-06	1.46e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—SRC—hematologic cancer	1.47e-06	1.45e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—SRC—hematologic cancer	1.46e-06	1.45e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—SRC—hematologic cancer	1.46e-06	1.44e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—HRAS—hematologic cancer	1.46e-06	1.44e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6—hematologic cancer	1.46e-06	1.44e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ALB—hematologic cancer	1.46e-06	1.44e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—SRC—hematologic cancer	1.46e-06	1.44e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—VEGFA—hematologic cancer	1.45e-06	1.44e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MYC—hematologic cancer	1.45e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TGFB1—hematologic cancer	1.45e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—SRC—hematologic cancer	1.44e-06	1.43e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—STAT3—hematologic cancer	1.44e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—SRC—hematologic cancer	1.44e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.44e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NRAS—hematologic cancer	1.44e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TP53—hematologic cancer	1.43e-06	1.42e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	1.43e-06	1.41e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—VEGFA—hematologic cancer	1.43e-06	1.41e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—AKT1—hematologic cancer	1.43e-06	1.41e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	1.42e-06	1.41e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	1.42e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—STAT3—hematologic cancer	1.42e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—STAT3—hematologic cancer	1.41e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NRAS—hematologic cancer	1.41e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.41e-06	1.4e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NRAS—hematologic cancer	1.41e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—STAT3—hematologic cancer	1.41e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.41e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—KRAS—hematologic cancer	1.41e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NRAS—hematologic cancer	1.4e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	1.4e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—STAT3—hematologic cancer	1.4e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NRAS—hematologic cancer	1.4e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	1.4e-06	1.39e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—KRAS—hematologic cancer	1.4e-06	1.38e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6—hematologic cancer	1.4e-06	1.38e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.39e-06	1.38e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—STAT3—hematologic cancer	1.39e-06	1.38e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NRAS—hematologic cancer	1.39e-06	1.37e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	1.39e-06	1.37e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	1.38e-06	1.37e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MAPK3—hematologic cancer	1.37e-06	1.36e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—HRAS—hematologic cancer	1.37e-06	1.36e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTEN—hematologic cancer	1.36e-06	1.34e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	1.35e-06	1.34e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MAPK3—hematologic cancer	1.35e-06	1.34e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AKT1—hematologic cancer	1.35e-06	1.33e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	1.35e-06	1.33e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	1.34e-06	1.33e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—KRAS—hematologic cancer	1.34e-06	1.33e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MYC—hematologic cancer	1.34e-06	1.32e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TGFB1—hematologic cancer	1.33e-06	1.32e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.33e-06	1.32e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	1.33e-06	1.31e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	1.32e-06	1.31e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PIK3CA—hematologic cancer	1.32e-06	1.31e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.32e-06	1.3e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MYC—hematologic cancer	1.32e-06	1.3e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6—hematologic cancer	1.31e-06	1.3e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MYC—hematologic cancer	1.31e-06	1.3e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	1.31e-06	1.3e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TGFB1—hematologic cancer	1.31e-06	1.3e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MYC—hematologic cancer	1.31e-06	1.29e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	1.31e-06	1.29e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MYC—hematologic cancer	1.3e-06	1.29e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	1.3e-06	1.29e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.3e-06	1.28e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—EP300—hematologic cancer	1.3e-06	1.28e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	1.29e-06	1.28e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MYC—hematologic cancer	1.29e-06	1.28e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AKT1—hematologic cancer	1.29e-06	1.27e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	1.29e-06	1.27e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MYC—hematologic cancer	1.29e-06	1.27e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.29e-06	1.27e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	1.29e-06	1.27e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	1.28e-06	1.27e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.26e-06	1.25e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TP53—hematologic cancer	1.25e-06	1.24e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ALB—hematologic cancer	1.25e-06	1.23e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TP53—hematologic cancer	1.24e-06	1.23e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—KRAS—hematologic cancer	1.24e-06	1.22e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—PIK3CA—hematologic cancer	1.23e-06	1.22e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTEN—hematologic cancer	1.22e-06	1.21e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—AKT1—hematologic cancer	1.22e-06	1.21e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—KRAS—hematologic cancer	1.22e-06	1.2e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—KRAS—hematologic cancer	1.21e-06	1.2e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AKT1—hematologic cancer	1.21e-06	1.2e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—KRAS—hematologic cancer	1.21e-06	1.2e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—KRAS—hematologic cancer	1.2e-06	1.19e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—HRAS—hematologic cancer	1.2e-06	1.18e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—KRAS—hematologic cancer	1.19e-06	1.18e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.19e-06	1.18e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TP53—hematologic cancer	1.19e-06	1.18e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	1.19e-06	1.18e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—HRAS—hematologic cancer	1.19e-06	1.18e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—EP300—hematologic cancer	1.16e-06	1.15e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6—hematologic cancer	1.14e-06	1.13e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HRAS—hematologic cancer	1.14e-06	1.13e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6—hematologic cancer	1.14e-06	1.13e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	1.13e-06	1.12e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTEN—hematologic cancer	1.12e-06	1.11e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	1.12e-06	1.1e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.12e-06	1.1e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	1.11e-06	1.1e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.11e-06	1.1e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTEN—hematologic cancer	1.11e-06	1.1e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	1.11e-06	1.1e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.11e-06	1.1e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	1.11e-06	1.1e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.1e-06	1.09e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TP53—hematologic cancer	1.1e-06	1.09e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	1.1e-06	1.08e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	1.09e-06	1.08e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6—hematologic cancer	1.09e-06	1.08e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—AKT1—hematologic cancer	1.08e-06	1.07e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TP53—hematologic cancer	1.08e-06	1.07e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TP53—hematologic cancer	1.08e-06	1.07e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TP53—hematologic cancer	1.07e-06	1.06e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TP53—hematologic cancer	1.07e-06	1.06e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—EP300—hematologic cancer	1.07e-06	1.06e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—EP300—hematologic cancer	1.06e-06	1.05e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TP53—hematologic cancer	1.06e-06	1.05e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TP53—hematologic cancer	1.06e-06	1.05e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AKT1—hematologic cancer	1.06e-06	1.04e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AKT1—hematologic cancer	1.05e-06	1.04e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HRAS—hematologic cancer	1.05e-06	1.04e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—HRAS—hematologic cancer	1.03e-06	1.02e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HRAS—hematologic cancer	1.03e-06	1.02e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HRAS—hematologic cancer	1.03e-06	1.02e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.03e-06	1.02e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HRAS—hematologic cancer	1.02e-06	1.01e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HRAS—hematologic cancer	1.01e-06	1e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	1.01e-06	1e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AKT1—hematologic cancer	1.01e-06	9.95e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6—hematologic cancer	1e-06	9.94e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6—hematologic cancer	9.89e-07	9.78e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6—hematologic cancer	9.87e-07	9.76e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6—hematologic cancer	9.83e-07	9.73e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6—hematologic cancer	9.8e-07	9.7e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CD—hematologic cancer	9.74e-07	9.64e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6—hematologic cancer	9.71e-07	9.61e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6—hematologic cancer	9.68e-07	9.58e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ALB—hematologic cancer	9.62e-07	9.51e-06	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PIK3CA—hematologic cancer	9.59e-07	9.49e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTEN—hematologic cancer	9.51e-07	9.41e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AKT1—hematologic cancer	9.27e-07	9.17e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3R1—hematologic cancer	9.2e-07	9.1e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AKT1—hematologic cancer	9.12e-07	9.03e-06	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—AKT1—hematologic cancer	9.11e-07	9.02e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AKT1—hematologic cancer	9.1e-07	9.01e-06	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—AKT1—hematologic cancer	9.09e-07	9e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AKT1—hematologic cancer	9.07e-07	8.98e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—EP300—hematologic cancer	9.07e-07	8.97e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AKT1—hematologic cancer	9.04e-07	8.95e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AKT1—hematologic cancer	8.96e-07	8.86e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	8.93e-07	8.84e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CA—hematologic cancer	8.61e-07	8.52e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CB—hematologic cancer	8.49e-07	8.4e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CA—hematologic cancer	7.92e-07	7.83e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CA—hematologic cancer	7.85e-07	7.77e-06	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—AKT1—hematologic cancer	7.83e-07	7.75e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTEN—hematologic cancer	7.34e-07	7.26e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—AKT1—hematologic cancer	7.03e-07	6.96e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—EP300—hematologic cancer	7e-07	6.92e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CA—hematologic cancer	6.71e-07	6.64e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AKT1—hematologic cancer	6.47e-07	6.4e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AKT1—hematologic cancer	6.41e-07	6.34e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AKT1—hematologic cancer	5.48e-07	5.42e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.18e-07	5.12e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AKT1—hematologic cancer	4.23e-07	4.18e-06	CbGpPWpGaD
